RD102
/ IASO BIO
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 13, 2021
A novel full-human CD22-CAR T cell therapy with potent activity against CD22 B-ALL.
(PubMed, Blood Cancer J)
- No abstract available
CAR T-Cell Therapy • Journal • CD22
1 to 1
Of
1
Go to page
1